Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery - Trocóniz, I F; Tillmann, C; Liesenfeld, K H; Schäfer, H G; Stangier, J (J Clin Pharmacol, 2007)